Partner With Us
Home01 About Us02 Science & Technology03 Research & Projects04 Collaboration05 Insights & Publications06 Careers07 Contact Us08
Partner With Us
Section 31 • Get in Touch

Let's Build the Future of Precision Medicine Together

Whether you are a researcher, healthcare organisation, technology company, pharmaceutical organisation or potential collaborator, we would like to hear from you.

Direct Channels

Connect With Shansons Precix

Select the most relevant channel for your inquiry or scientific proposal:

Research Collaboration

Discuss scientific collaboration opportunities and joint grant research.

Technology Partnership

Explore technology and analytical platform partnerships across NGS and bioinformatics.

Clinical Collaboration

Discuss potential clinical research opportunities under approved ethical governance.

Business Enquiries

Connect with our executive team for corporate and biotechnology partnerships.

Careers

Explore opportunities to become part of our multidisciplinary team.

Scientific Router

Send an Enquiry

Please complete the details below and our team will route your message to the appropriate scientific division:

Section 32 • Knowledge Base

Frequently Asked Questions

Comprehensive scientific, technological, and operational answers regarding precision medicine and Shansons Precix.

Precision medicine is an approach to healthcare that considers individual genetic, molecular and other biological characteristics to support more personalised approaches to disease prevention, diagnosis and treatment.
Precision oncology applies molecular and genetic information to better understand individual cancers and investigate personalised approaches to cancer care.
Next-Generation Sequencing is a group of advanced sequencing technologies used to analyse genetic material at high throughput with high accuracy and deep coverage.
Liquid biopsy is a minimally invasive approach that investigates disease-associated biological material found in body fluids such as blood, including circulating tumour DNA (ctDNA).
Pharmacogenetics studies how genetic differences can influence an individual's response to medicines, including drug metabolism, transport, efficacy, and adverse reaction risks.
Genomic profiling can provide information about genetic alterations and molecular characteristics that may be relevant to disease research and personalised healthcare.
The website clearly distinguishes research, diagnostic capabilities and clinical treatment. Any treatment claims should only be published once the relevant clinical capabilities and regulatory requirements are confirmed.